Member Info for Okehurst1

Hi Kate
Really sorry to see you are down 60%, can see your hurting a lot, there are many on this BB who have lost money and I hope you have someone to talk to and work through the situation.

Appreciate we are all behind a key board and only known by our BB name but for what it’s worth try and switch off for the weekend and wait for this one to hopefully get back to 60p - which appears to be your buy price

I thought Colin was a genuine guy but after his performance I’ve learnt a hard lesson to never trust an AIM co CEO on his tweets / blurb ,actual results via an RNS going forward only.

Colin should do the decent thing and resign or the Chairman dismisses him and we bring on board a commercial operator.

Feel Colin sold us all ;

‘sunlight but delivered moonlight ‘

Still holding but lesson learnt not to trust anything except results

We know there is a serious shortage of Antigen LFT’s in the USA

Looks like the FDA are churning out approvals, 6 in the past week - alongside binning poor performance tests

Let’s hope Bill Gates is putting a bit of pressure on from his side
would be a boost for the shares alongside U.K. CTDA

https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2

Scaff, sorry to hear your at a loss here.

Either before or on the morning of the results I think we have a decent chance we will hear we have cleared CTDA ‘in clinic ‘ professional use.
potentially a lucrative market with the DAM link up

Am hoping EU HUA / U.K. HUA closely follows

Scary numbers from WHO

https://www.theguardian.com/world/2021/nov/20/covid-deaths-europe-who-warning-

Professional use ( in clinic ) CTDA RNS this week
If DAM staff are correct

https://www.dam-health.com/

Hopefully to follow , HUA U.K. / EU HUA

https://www.gov.uk/government/publications/minimum-standards-for-private-sector-providers-of-covid-19-testing/day-2-lateral-flow-tests-for-international-arrivals-minimum-standards-for-providers

Nobby, this deserves a bump

Captain
Am not too sure re squeaky bum time this week, it’s took time but Omega well placed

Europe heading to full on 4th wave
DAM Health In Clinic to start using Omega LFT’s
DHSC manufacturing opportunities
U.K. HUA imminent
EU HUA same
USA commercial use

Everything is set up / in place , 100M plus capacity
one of the largest in Europe
Bill Gates Biotech / contacts, provides us with a level of gravitas.
Omega, a respected diagnostics engineer.

No debt of note £6M in bank as of a few weeks ago.

Hopefully you will get your investment £money and more back quite soon

Suggest we may see an RNS next week advising DAM are now using Omega LFT for day 2 vaccinated travellers - as per email from DAM rep

Observations - URL below

- Extensive in clinic DAM U.K. network
- £29 net per test - we must be enjoying a decent margin
- Test at Home coming soon

https://www.dam-health.com/fully-vaccinated-day-2-antigen/

Updated this week

It may well be this is the initial market next week for Omega with DAM, as inferred by their sale rep, be that in clinic / or of their stores ?

HUA to follow

https://www.gov.uk/government/publications/minimum-standards-for-private-sector-providers-of-covid-19-testing/day-2-lateral-flow-tests-for-international-arrivals-minimum-standards-for-providers

Flashy
Taking the view DAM won’t be legally allowed to sell the Omega test until it clears CTDA - unless it passed PD- it’s intriguing to know how DAM are selling the test from next week in clinic?

Unless am missing something this implies we will clear CTDA beforehand?

Morning TW - fair debate.

The DAM rep mentions available for in -clinic use next week, I was taking the view this implies the Omega test is back in commercial use and must have cleared CTDA or some other regulatory hurdle as they have informed the market they had to withdraw the LFT with everyone else whilst they reapplied / cleared CTDA.

That was my take - May be wrong

Sweden thought they could reduce Covid testing, didn’t quite work out for them.

https://www.reuters.com/world/europe/swedish-health-agency-backtracks-reduced-covid-testing-2021-11-17/

Decent thread - thanks Shredz

If DAM are correct then next week we secure HUA for U.K. travel
we may have already had the verbal nod -hence step up at Alva- and
Omega will then have it in writing/ RNS at that point

Think this is now looking highly likely

EU HUA ?
DHSC contract ?
USA CE

All to follow next few weeks but at £20 net per LFT retail via the DAM outlets we must on for a decent gross profit

40p on the offer this week will look like a steal as this plays out before Xmas

https://twitter.com/shredz90/status/1461670385359937538?s=10

Agree Tricky, this was interesting

https://twitter.com/eazy_investor/status/1461696615249596416?s=10

Looks like game on

With the 4th wave hitting Europe and even fully vaccinated people being admitted to hospital on the mainland it appears Covid 19 is going to be here for quite sometime.

On securing HUA / generating cash suggest Omega should acquire DAM
use the ££ to pick up their distribution network

It makes sense, DAM look like they know how to sell, Omega are a top class diagnostic engineer who have a proven record of partnerships and are well respected but they just don’t have selling produce in their DNA

Could be the perfect fit and a good use of the cash, earnings enhancing same time.

Omega becomes a vertical operator.

When do they make their move ?

It’s going to get interesting

Medusa must have a decent idea of where they are gaining EU approval?

On the news of success with EU HUA it will be interesting to see how Juniper react ?Or will they move beforehand and try and bank a profit?

EU HU market of 447M people is a serious opportunity on its own merits, Juniper could get toasted.

Calder,
It’s almost 12 months since DHSC have owed £8M to the RTC and still not paid up, yet the Government says it wants to support the U.K. diagnostics market and at the same pays £Billions out to Chinese companies, difficult to comprehend.